SBIR/STTR TABA Changes: More Than a Minor Budget Update
The new SBIR/STTR TABA rules change who can use funds, how they can be used, and why proposal strategy matters more.
Sharing best practices, tips, anything that shows our expertise.
The new SBIR/STTR TABA rules change who can use funds, how they can be used, and why proposal strategy matters more.
SBIR is reauthorized. Heightened oversight makes independent evaluation a strategic advantage for applicants in upcoming funding cycles
NIH’s “competitive but not discussed” designation reflects review compression, not automatic rejection, and still carries real funding potential.
BAAs offer a faster, more flexible path to DoW funding, especially for early-stage innovations still evolving toward real-world application.
NIH’s new DMS Plan format reduces narrative burden, but expectations for data sharing strategy and compliance remain firmly in place.
NSF IUSE: EDU proposals require more than strong ideas. Evaluation determines competitiveness, credibility, and whether your project demonstrates measurable impact.
Direct to Phase II expansion to NASA, DOE, and STTR shifts how innovators must demonstrate readiness and align with agency funding priorities.
Stand out with a winning SBIR/STTR proposal! Craft a clear, innovative, and impactful technical narrative that captures reviewers’ attention.
NIH’s Current and Pending Support form influences feasibility, risk, and review outcomes more than most applicants realize during proposal development.
NIH Highlighted Topics are not funding calls. Learn how to use them strategically to align proposals and improve funding outcomes.